| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.024 | 0.7 |